On January 29, the Supreme Court scheduled oral arguments to be held in March for Alliance for Hippocratic Medicine v. FDA, a case challenging decisions by the FDA to eliminate key regulations of the abortion drug mifepristone. Just one week later, a key study on mifepristone safety – which I coauthored – was retracted.

Keep reading at RealClearHealth >>